[Code of Federal Regulations]
[Title 21, Volume 9]
[Revised as of April 1, 2007]
From the U.S. Government Printing Office via GPO Access
[CITE: 21CFR1308.13]
[Page 96-98]
TITLE 21-FOOD AND DRUGS
CHAPTER II--DRUG ENFORCEMENT ADMINISTRATION, DEPARTMENT OF JUSTICE
PART 1308_SCHEDULES OF CONTROLLED SUBSTANCES--Table of Contents
Sec. 1308.13 Schedule III.
(a) Schedule III shall consist of the drugs and other substances, by
whatever official name, common or usual name, chemical name, or brand
name designated, listed in this section. Each drug or substance has been
assigned the DEA Controlled Substances Code Number set forth opposite
it.
(b) Stimulants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a stimulant
effect on the central nervous sxstem, including its salts, isomers
(whether optical, position, or geometric), and salts of such isomers
whenever the existence of such salts, isomers, and salts of isomers is
possible within the specific chemical designation:
(1) Those compounds, mixtures, or preparations in dosage unit 1405
form containing any stimulant substances listed in schedule II
which compounds, mixtures, or preparations were listed on August
25, 1971, as excepted compounds under Sec. 1308.32, and any
other drug of the quantitative composition shown in that list
for those drugs or which is the same except that it contains a
lesser quantity of controlled substances........................
(2) Benzphetamine................................................ 1228
[[Page 97]]
(3) Chlorphentermine............................................. 1645
(4) Clortermine.................................................. 1647
(5) Phendimetrazine.............................................. 1615
(c) Depressants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a depressant
effect on the central nervous system:
(1) Any compound, mixture or preparation containing:
(i) Amobarbital.............................................. 2126
(ii) Secobarbital............................................ 2316
(iii) Pentobarbital.......................................... 2271
or any salt thereof and one or more other active medicinal
ingredients which are not listed in any schedule.
(2) Any suppository dosage form containing:
(i) Amobarbital.............................................. 2126
(ii) Secobarbital............................................ 2316
(iii) Pentobarbital.......................................... 2271
or any salt of any of these drugs and approved by the Food and
Drug Administration for marketing only as a suppository.
(3) Any substance which contains any quantity of a derivative of 2100
barbituric acid or any salt thereof.............................
(4) Chlorhexadol................................................. 2510
(5) Embutramide.................................................. 2020
(6) Any drug product containing gamma hydroxybutyric acid, 2012
including its salts, isomers, and salts of isomers, for which an
application is approved under section 505 of the Federal Food,
Drug, and Cosmetic Act..........................................
(7) Ketamine, its salts, isomers, and salts of isomers........... 7285
[Some other names for ketamine: ()-2-(2-
chlorophenyl)-2-(methylamino)-cyclohexanone]
(8) Lysergic acid................................................ 7300
(9) Lysergic acid amide.......................................... 7310
(10) Methyprylon................................................. 2575
(11) Sulfondiethylmethane........................................ 2600
(12) Sulfonethylmethane.......................................... 2605
(13) Sulfonmethane............................................... 2610
(14) Tiletamine and zolazepam or any salt thereof................ 7295
Some trade or other names for a tiletamine-zolazepam
combination product:
Telazol......................................................
Some trade or other names for tiletamine:
2-(ethylamino)-2-(2-thienyl)-cyclohexanone...................
Some trade or other names for zolazepam:
4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-
e] [1,4]-diazepin-7(1H)-one, flupyrazapon...................
(d) Nalorphine 9400.
(e) Narcotic drugs. Unless specifically excepted or unless listed in
another schedule:
(1) Any material, compound, mixture, or preparation containing
any of the following narcotic drugs, or their salts calculated
as the free anhydrous base or alkaloid, in limited quantities as
set forth below:
(i) Not more than 1.8 grams of codeine per 100 milliliters or 9803
not more than 90 milligrams per dosage unit, with an equal
or greater quantity of an isoquinoline alkaloid of opium....
(ii) Not more than 1.8 grams of codeine per 100 milliliters 9804
or not more than 90 milligrams per dosage unit, with one or
more active, nonnarcotic ingredients in recognized
therapeutic amounts.........................................
(iii) Not more than 300 milligrams of dihydrocodeinone 9805
(hydrocodone) per 100 milliliters or not more than 15
milligrams per dosage unit, with a fourfold or greater
quantity of an isoquinoline alkaloid of opium...............
(iv) Not more than 300 milligrams of dihydrocodeinone 9806
(hydrocodone) per 100 milliliters or not more than 15
milligrams per dosage unit, with one or more active
nonnarcotic ingredients in recognized therapeutic amounts...
(v) Not more than 1.8 grams of dihydrocodeine per 100 9807
milliliters or not more than 90 milligrams per dosage unit,
with one or more active nonnarcotic ingredients in
recognized therapeutic amounts..............................
(vi) Not more than 300 milligrams of ethylmorphine per 100 9808
milliliters or not more than 15 milligrams per dosage unit,
with one or more active, nonnarcotic ingredients in
recognized therapeutic amounts..............................
(vii) Not more than 500 milligrams of opium per 100 9809
milliliters or per 100 grams or not more than 25 milligrams
per dosage unit, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts...............
(viii) Not more than 50 milligrams of morphine per 100 9810
milliliters or per 100 grams, with one or more active,
nonnarcotic ingredients in recognized therapeutic amounts...
(2) Any material, compound, mixture, or preparation containing
any of the following narcotic drugs or their salts, as set forth
below:
(i) Buprenorphine............................................ 9064
(ii) [Reserved]..............................................
(f) Anabolic Steroids. Unless specifically excepted or unless listed
in another schedule, any material, compound, mixture or preparation
containing any quantity of the following substances, including its
salts, esters and ethers:
(1) Anabolic steroids (see Sec. 1300.01 of this chapter)--4000
(2) [Reserved]
(g) Hallucinogenic substances. (1) Dronabinol (synthetic) in sesame
oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug
Administration approved product--7369.
[Some other names for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-
6,6,9-trimethyl-3-pentyl-6H-dibenzo [b,d]pyran-1-ol] or (-)-delta-9-
(trans)-tetrahydrocannabinol]
[[Page 98]]
(2) [Reserved]
[39 FR 22142, June 20, 1974, as amended at 41 FR 43401, Oct. 1, 1976; 43
FR 3359, Jan. 25, 1978; 44 FR 40888, July 13, 1979; 46 FR 52334, Oct.
27, 1981; 51 FR 5320, Feb. 13, 1986; 52 FR 2222, Jan. 21, 1987; 52 FR
5952, Feb. 27, 1987; 56 FR 5754, Feb. 13, 1991; 56 FR 11932, Mar. 21,
1991; 62 FR 13968, Mar. 24, 1997; 64 FR 35930, July 2, 1999; 64 FR
37675, July 13, 1999; 65 FR 13238, Mar. 13, 2000; 65 FR 17440, Apr. 3,
2000; 67 FR 62370, Oct. 7, 2002; 70 FR 74657, Dec. 16, 2005; 71 FR
51116, Aug. 29, 2006]